Callan Family Office’s Broadridge BR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.57M Buy
18,765
+1,727
+10% +$261K 0.05% 323
2026
Q1
$2.77M Buy
17,038
+1,531
+10% +$291K 0.06% 287
2025
Q4
$3.46M Buy
15,507
+8,863
+133% +$2.02M 0.07% 242
2025
Q3
$1.58M Sell
6,644
-147
-2% -$36.6K 0.05% 298
2025
Q2
$1.65M Buy
6,791
+1,288
+23% +$306K 0.05% 300
2025
Q1
$1.33M Sell
5,503
-3
-0.1% -$706 0.1% 174
2024
Q4
$1.24M Buy
+5,506
New +$1.23M 0.08% 211

Other funds holding BR

Callan Family Office's BR Position: Q2 2026 in Review

Callan Family Office increased its Broadridge (BR) stake by 10% in Q2 2026, buying an estimated $261K and bringing the position to 18,765 shares worth $2.57M. The position accounts for 0.05% of the portfolio, ranked #323.

Callan Family Office first reported a position in BR in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.46M in Q4 2025. 1,021 funds tracked by Wall St. Rank hold BR as of Q2 2026.

  • Callan Family Office held 18,765 shares of Broadridge worth $2.57M as of Q2 2026.
  • Callan Family Office bought 1,727 Broadridge shares in Q2 2026, an estimated $261K.
  • Broadridge made up 0.05% of Callan Family Office's portfolio in Q2 2026, its #323 holding.
  • Callan Family Office first reported a position in Broadridge in Q4 2024 and has held it in 7 quarters since.
  • Callan Family Office's Broadridge position peaked at $3.46M in Q4 2025.
  • 1,021 funds tracked by Wall St. Rank held Broadridge as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.